Health spending in the U.S. is projected to accelerate in the next decade. Stanford professor Kevin Schulman offers an explanation.
Retail prices at pharmacies may bear little relationship to the actual market prices of medications, and pharmacy benefit managers are part of the reason.
Proponents say a "Medicare for All" approach would expand access and affordability of health care in the U.S. But there are practical downsides.